News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 805 results

US Senators urge FTC to closely scrutinise pharma mergers

US19-09-2019Saman Javed

A group of senators has urged the US Federal Trade Commission to closely scrutinise mergers in the pharmaceutical industry, which it said “increase competition issues and stifle innovation”.

Duke and Allergan escape antitrust claims in Akorn suit

US19-09-2019Sarah Morgan

A US judge dismissed antitrust counterclaims brought against Allergan and Duke University earlier this week, in a lawsuit the pair filed against generics maker Akorn.

AIPPI World Congress 2019: SPC and PTEs around the world

EU, Japan, US17-09-2019Saman Javed

This week at the AIPPI World Congress 2019, counsel discussed how supplementary protection certificates and patent term extension regulations differ across jurisdictions.

Vectura wins additional $10m patent damages against GSK

US16-09-2019Saman Javed

A district court has upped Vectura’s award of $89.7 million in damages by $10m, after a jury trial earlier this year found that GlaxoSmithKline has willfully infringed one of its patents.

Pharma industry challenges Canada’s drug pricing plan

Canada09-09-2019Sarah Morgan

Innovative Medicines Canada, an association that represents drugmakers in Canada, has challenged the overhaul of Canada’s drug-pricing regime.

Federal Circuit blocks Sandoz generic

US30-08-2019Rory O'Neill

The US Court of Appeals for the Federal Circuit has ruled that claims in an Allergan patent detailing the results of a glaucoma treatment are material to its patentability, after an unsuccessful invalidation appeal brought by Sandoz.

Delhi court approves Natco generic of Novartis cancer drug

Asia, India29-08-2019Rory O'Neill

The Delhi High Court has cleared the way for a generic version of Novartis’ small-cell lung cancer drug Ceritinib, after the Swiss pharmaceutical company’s patent was revoked.

PTAB institutes IPR of Nalox-1 opioid overdose treatment

US29-08-2019Saman Javed

The US Patent Trial and Appeal Board has instituted an inter partes review into a patent covering an opioid overdose treatment owned by Nalox-1 Pharmaceuticals.

Takeda subsidiary ordered to pay Bayer $182m after overturn bid fails

US27-08-2019Saman Javed

A Takeda subsidiary cannot overturn a $155 million jury verdict that it infringed one of Bayer’s patents, a district court has ruled.

Gilead challenges US govt patents on HIV drug Truvada

US22-08-2019

Gilead Sciences, the maker of HIV drug Truvada, has asked the US Patent and Trademark Office to review patents granted to the government covering preventative use of the drug. 

Showing 1 to 10 of 805 results

LSIPR